Diabetes Drugs Show Promise in Reducing Amyloid Protein
The medical consequences of uncontrolled diabetes are well known. However, much less is known about the potential neurologic effects that common diabetic treatments may have in lessening possible effects on the brain. A new study suggests a benefit of dipeptidyl peptidase-4 inhibitors (DPP-4i) on reducing the accumulation of amyloid protein in the brain, a hallmark of Alzheimer's disease. Read more.

Study: Treatment Adherence in Comorbid Depression and Diabetes Leads to Better Outcomes
According to a recent retrospective cohort study, individuals who are both diabetic and depressed, but are adherent to taking their medications, have less risk of serious disease complications and death compared with peers who do not take their medications. Because depression is common in chronic diseases such as diabetes, these results may have value for efforts to reinforce adherence. Read more.